Skip to content
10-Q

Quarterly Report

Flexion Therapeutics, Inc.

0000950170-21-000785

← back to feed
Filed
Aug 4, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Aug 1, 2021 50.29M sh
Capex Q2 2021 · Jun 30, 2021 $1.27M
Capex Q2 2021 · Jun 30, 2020 $5.54M
Operating Cash Flow Q2 2021 · Jun 30, 2021 −$37.24M
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$48.61M
Long Term Debt Q2 2021 · Jun 30, 2021 $52.21M
Long Term Debt Q2 2021 · Dec 31, 2020 $44.11M
Short Term Debt Q2 2021 · Jun 30, 2021 $1.53M
Short Term Debt Q2 2021 · Dec 31, 2020 $16.81M
Cash And Equivalents Q2 2021 · Jun 30, 2021 $107.63M
Cash And Equivalents Q2 2021 · Dec 31, 2020 $107.7M
Stockholders Equity Q2 2021 · Jun 30, 2021 −$56.17M
Stockholders Equity Q2 2021 · Mar 31, 2021 −$38.87M
Stockholders Equity Q2 2021 · Dec 31, 2020 −$16.66M
Stockholders Equity Q2 2021 · Jun 30, 2020 $16.52M
Stockholders Equity Q2 2021 · Mar 31, 2020 −$52.31M
Stockholders Equity Q2 2021 · Dec 31, 2019 −$20.11M
Current Liabilities Q2 2021 · Jun 30, 2021 $39.93M
Current Liabilities Q2 2021 · Dec 31, 2020 $55.27M
Total Liabilities Q2 2021 · Jun 30, 2021 $266.22M
Total Liabilities Q2 2021 · Dec 31, 2020 $268.59M
Current Assets Q2 2021 · Jun 30, 2021 $184.12M
Current Assets Q2 2021 · Dec 31, 2020 $225.81M
Total Assets Q2 2021 · Jun 30, 2021 $210.05M
Total Assets Q2 2021 · Dec 31, 2020 $251.93M
Sga Expense Q2 2021 · Jun 30, 2021 $27.41M
Sga Expense Q2 2021 · Jun 30, 2021 $55.01M
Sga Expense Q2 2021 · Jun 30, 2020 $24.73M
Sga Expense Q2 2021 · Jun 30, 2020 $54.03M
Rd Expense Q2 2021 · Jun 30, 2021 $12.67M
Rd Expense Q2 2021 · Jun 30, 2021 $26.72M
Rd Expense Q2 2021 · Jun 30, 2020 $12.51M
Rd Expense Q2 2021 · Jun 30, 2020 $33.64M
Net Income Q2 2021 · Jun 30, 2021 −$22.21M
Net Income Q2 2021 · Jun 30, 2021 −$50.76M
Net Income Q2 2021 · Mar 31, 2021 −$28.56M
Net Income Q2 2021 · Jun 30, 2020 −$32.62M
Net Income Q2 2021 · Jun 30, 2020 −$69.42M
Net Income Q2 2021 · Mar 31, 2020 −$36.8M
Operating Income Q2 2021 · Jun 30, 2021 −$16.88M
Operating Income Q2 2021 · Jun 30, 2021 −$40.02M
Operating Income Q2 2021 · Jun 30, 2020 −$27.27M
Operating Income Q2 2021 · Jun 30, 2020 −$59.85M
Cost Of Revenue Q2 2021 · Jun 30, 2021 $4.98M
Cost Of Revenue Q2 2021 · Jun 30, 2021 $11.06M
Cost Of Revenue Q2 2021 · Jun 30, 2020 $5.48M
Cost Of Revenue Q2 2021 · Jun 30, 2020 $7.76M
Revenue Q2 2021 · Jun 30, 2021 $28.18M
Revenue Q2 2021 · Jun 30, 2021 $52.76M
Revenue Q2 2021 · Jun 30, 2020 $15.45M
Revenue Q2 2021 · Jun 30, 2020 $35.58M